Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.

Vaccine - 1 Jan 1999

Herlocher M L, Ewasyshyn M, Sambhara S, Gharaee-Kermani M, Cho D, Lai J, Klein M, Maassab H F

Abstract excerpt

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in infants, young children, and the elderly. Efforts to develop satisfactory live or inactivated vaccines have not yet been proven successful. Our research focuses on the development of four purified live attenuated RSV sub-type A human vaccine clones. Temperature sensitive (ts) and attenuated purified clones of either cold-adapted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Neutralization Tests

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Respiratory Syncytial Virus Infections

Share to Respiratory Syncytial Viruses

Share to T-Lymphocytes, Cytotoxic

Share to Vaccines, Attenuated

Share to Viral Vaccines

Share to Virus Cultivation

Source

Identifiers

PMID: 9987152
DOI: 10.1016/s0264-410x(98)00155-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.PMID 9987152Read ↗

Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines.Semantic proximity Read ↗

Evaluation of the Safety and Immune Efficacy of Recombinant Human Respiratory Syncytial Virus Strain Long Live Attenuated Vaccine CandidatesSemantic proximity Read ↗

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children.Semantic proximity Read ↗

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Semantic proximity Read ↗

Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.Semantic proximity Read ↗

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.Semantic proximity Read ↗

Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase ProteinSemantic proximity Read ↗

Live-Attenuated Intranasal RSV Vaccine in Infants and ToddlersSemantic proximity Read ↗

Evaluation of a novel recombinant strain of infectious bronchitis virus emerged from three attenuated live vaccine strainsSemantic proximity Read ↗

Challenges in developing a pediatric RSV vaccineSemantic proximity Read ↗

Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes.Semantic proximity Read ↗

[Live cold-adapted influenza vaccine: state-of-the-art].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.